KLRA Kailera Therapeutics, Inc.

Fundamentals / CIK 0002096997 / USD

Kailera Therapeutics, Inc. reported $1.08B in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KLRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for KLRA.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $84.67M $101.1M $70.87M $26.99M $19.52M $10.13M
Total Operating Expenses $106.3M $121.4M $84.66M $40.11M $30.65M $20.46M
Operating Income -$106.3M -$121.4M -$84.66M -$40.11M -$30.65M -$20.46M
EBITDA -$106.2M -$121.3M -$84.56M -$40.05M -$30.59M -$20.39M
Net Income -$95.67M -$111.3M -$78.86M -$39.62M -$28.95M -$17.98M
Basic EPS -$0.74 -$1.09 -$3,650.00 -$39,623.00 -$28,947.00 -$17,983.00
Diluted EPS -$0.74 -$1.09 -$3,650.00 -$39,623.00 -$28,947.00 -$17,983.00
Basic Shares Outstanding 129.7M 102.2M 21.6K 1 1 1
Diluted Shares Outstanding 129.7M 102.2M 21.6K 1 1 1

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for KLRA.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $106.5M $130.3M $111.8M $160.3M
Short-Term Investments $794.9M $786.4M $407.3M $385.8M
Cash & Short-Term Investments $1.04B $1.17B $581.9M $546.1M
Other Current Assets $4.89M $395K $360K $4.22M
Total Current Assets $919.8M $929.2M $530.3M $557.5M
Property, Plant & Equipment, Net $1.65M $1.75M $1.85M $1.96M
Long-Term Investments $136.2M $255.1M $62.75M $106.7M
Other Non-Current Assets $63K $90K $5.59M $2.72M
Total Non-Current Assets $162.4M $282.2M $94.44M $134.8M
Total Assets $1.08B $1.21B $624.8M $692.3M
Accounts Payable $9.43M $19.20M $7.09M $7.53M
Total Current Liabilities $42.12M $83.65M $54.84M $46.41M
Other Non-Current Liabilities $67K $135K $201K $270K
Total Non-Current Liabilities $8.95M $9.30M $9.64M $9.98M
Total Liabilities $51.06M $92.95M $64.48M $56.39M
Total Debt (incl. Leases) $9.97M $10.22M $10.47M $10.75M
Common Stock $0 $0 $0 $0
Retained Earnings -$654.5M -$558.8M -$447.5M -$368.7M
Accumulated Other Comp. Income -$3.74M -$1.79M -$532K $229K
Total Stockholders' Equity $1.03B $1.12B -$432.1M -$356.5M
Total Equity $1.03B $1.12B -$432.1M -$356.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for KLRA.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$95.67M -$111.3M -$78.86M -$39.62M -$28.95M -$17.98M
Depreciation & Amortization $101K $101K $101K $63K $62K $63K
Stock-Based Compensation $9.92M $8.34M $3.94M $4.27M $1.63M $1.52M
Change in Payables -$9.77M $12.34M -$495K $154K -$837K $645K
Operating Cash Flow -$133.7M -$77.53M -$68.31M -$29.70M -$26.23M -$18.20M
Purchases of Investments -$37.06M -$689.8M -$48.45M -$42.28M -$82.17M -$54.44M
Investing Cash Flow $110.8M -$571.0M $22.85M $26.48M -$74.17M -$54.44M
Financing Cash Flow -$922K $667.0M -$2.98M -$243K $100.0M $0
Net Change in Cash -$23.76M $18.48M -$48.44M -$3.46M -$403K -$72.64M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for KLRA.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 21.84x 11.11x 9.67x -- -- --
Quick Ratio 24.64x 14.01x 10.61x -- -- --
Debt to Equity 0.01x 0.01x -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002096997) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:24 UTC · Open in terminal